生物制药公司Halozyme周三表示，荷兰专利法院裁定其在对默克的诉讼中胜诉，命令这家制药商停止在八个欧洲市场生产 and 销售注射型Keytruda。
Biopharma company Halozyme said on Wednesday that a Dutch patent court ruled in its favor against Merck , ordering the drugmaker to halt the manufacture and sale of injectable Keytruda in eight European markets.